Expand ENTX Menu
ENTX MENU

Entera Bio Ltd. - (ENTX) closed at $3.02 on November 16, 2026, down 2.9% from the previous close, on volume of 201,919 shares (30-day average 496,206).

Key numbers
  • Last close: $3.02 (November 16, 2026)
  • 52-week range: $0.91 to $4.20
  • Market value: $525.9 million
  • 30-day implied volatility (IV30): 61.9%
  • Option volume: 301 contracts (301 calls, 0 puts); 30-day average 164

Data as of November 16, 2026.

ENTX Stock Summary and Trading Ideas (Entera Bio Ltd. - | NASDAQ:ENTX)

Charts for Today's Stock Price and Implied Volatility in Entera Bio Ltd. -

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ENTX by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 13, 2026 Calendar Call Spread 20-Nov : 18-Dec-26 3 C 252

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the largest for 5, 30, 60 and 90 days

News

Entera to Participate in Upcoming Fall Investor Conferences

Globe Newswire (Thu, 27-Aug 8:00 AM ET)

Trading Statistics

Key Ratios

Entera Bio Ltd. - (ENTX) Frequently Asked Questions

What does Entera Bio Ltd. - do?

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

What symbol and exchange does Entera Bio Ltd. - shares trade?

Entera Bio Ltd. - trades on the NASDAQ stock market under the symbol ENTX.

What is Entera Bio Ltd. - stock price doing today?

As of November 16, 2026, ENTX stock price declined to $3.02 with 201,919 million shares trading.

What is Entera Bio Ltd. -'s Beta?

ENTX has a beta of -0.14, meaning it tends to be less sensitive to market movements. ENTX has a correlation of 0.00 to the broad based SPY ETF.

How much is Entera Bio Ltd. - worth?

ENTX has a market cap of $525.90 million. This is considered a Small Cap stock.

What is the highest and lowest price Entera Bio Ltd. - traded in the last 3 year period?

In the last 3 years, ENTX traded as high as $4.20 and as low as $.52.

What are the top ETFs holding Entera Bio Ltd. -?

The top ETF exchange traded funds that ENTX belongs to (by Net Assets): IZRL.

Is Entera Bio Ltd. - (ENTX) a good investment?

ENTX has underperformed the market in the last year with a price return of +10.2% while the SPY ETF gained +11.2%. However, in the short term, ENTX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.2% vs -4.6% return in SPY. But in the last 2 weeks, ENTX shares have been beat by the market, returning -5.6% compared to an SPY return of -2.1%.

What are the support and resistance levels for Entera Bio Ltd. - (ENTX)?

ENTX support price is $2.95 and resistance is $3.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENTX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes